These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26603238)

  • 1. PROTECTIVE LEVELS OF VARICELLA-ZOSTER ANTIBODY DID NOT EFFECTIVELY PREVENT CHICKENPOX IN AN X-LINKED AGAMMAGLOBULINEMIA PATIENT.
    Nobre FA; Gonzalez IG; de Moraes-Pinto MI; Costa-Carvalho BT
    Rev Inst Med Trop Sao Paulo; 2015; 57(5):455-7. PubMed ID: 26603238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection.
    Chris Maple PA; Gray J; Brown K; Brown D
    J Virol Methods; 2009 Apr; 157(1):90-2. PubMed ID: 19135089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
    Jenke AC; Klein S; Baiker A; Wirth S; Sander M; Noelting C; Boecher O; Vizoso-Pinto MG
    Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
    Sauerbrei A; Wutzler P
    J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of Varicella-Zoster virus (VZV)-specific T-cells before seroconversion in primary varicella infection: case report.
    Baiker A; Haase R; Eberle J; Vizoso Pinto MG; Pfrepper KI; Petrich A; Deml L; Campe H; Nitschko H; Jaeger G
    Virol J; 2010 Mar; 7():54. PubMed ID: 20205920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anti-varicella zoster IgG antibody in undergraduate students.
    Bhattarakosol P; Chantarabul S; Pittayathikhun K; Mung-mee V; Punnarugsa V
    Asian Pac J Allergy Immunol; 1996 Dec; 14(2):129-31. PubMed ID: 9177828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of chickenpox during pregnancy in women seropositive for varicella-zoster virus.
    Martin KA; Junker AK; Thomas EE; Van Allen MI; Friedman JM
    J Infect Dis; 1994 Oct; 170(4):991-5. PubMed ID: 7930746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella-zoster virus antibody avidity and IgG-subclass patterns in children with recurrent chickenpox.
    Junker AK; Tilley P
    J Med Virol; 1994 Jun; 43(2):119-24. PubMed ID: 8083659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.
    Paryani SG; Arvin AM; Koropchak CM; Wittek AE; Amylon MD; Dobkin MB; Budinger MD
    Am J Med; 1984 Mar; 76(3A):124-7. PubMed ID: 6324585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough varicella in a cancer patient with persistent varicella antibody after one varicella vaccination.
    Yamada M; Kamberos N; Grose C
    J Pediatr; 2013 Nov; 163(5):1511-3. PubMed ID: 23932212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella zoster virus in health care workers in northern Israel: seroprevalence and predictive value of history of varicella infection.
    Chazan B; Colodner R; Teitler N; Chen Y; Raz R
    Am J Infect Control; 2008 Aug; 36(6):436-8. PubMed ID: 18675150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
    Heininger U; Desgrandchamps D; Schaad UB
    Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
    Palumbo PE; Arvin AM; Koropchak CM; Wittek AE
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test.
    Enders G
    Postgrad Med J; 1985; 61 Suppl 4():23-30. PubMed ID: 3014475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interpretation of varicella serology in pregnancy].
    von Hintzenstern J; Jahn G
    Geburtshilfe Frauenheilkd; 1988 Dec; 48(12):859-62. PubMed ID: 2853094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nosocomial transmission of varicella to a healthcare provider positive for anti-varicella zoster virus antibodies: nonprotective positivity with an immune adherence hemagglutination assay.
    Hitomi S; Kudo T; Koganemaru H; Tsutsumi N
    J Infect Chemother; 2011 Oct; 17(5):710-2. PubMed ID: 21442468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Summary of the multidisciplinary guideline 'Varicella'].
    Rothbarth PH; Hartwig NG; Opstelten W
    Ned Tijdschr Geneeskd; 2011; 155(51):A3511. PubMed ID: 22200141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the performance of the LIAISON VZV-IgG and VIDAS automated enzyme linked fluorescent immunoassays with reference to a VZV-IgG time-resolved fluorescence immunoassay and implications of choice of cut-off for LIAISON assay.
    Maple PA; Rathod P; Smit E; Gray J; Brown D; Boxall EH
    J Clin Virol; 2009 Jan; 44(1):9-14. PubMed ID: 18823815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.